Gravidic intrahepatic cholestasis (also called intrahepatic cholestasis of pregnancy, ICP) is a liver problem that happens only in pregnancy. In this condition, the tiny tubes inside the liver that carry bile slow down. Bile acids then build up in the mother’s blood instead of flowing normally into the gut. This buildup causes strong itching, usually without a skin rash. The mother often feels well otherwise, but her blood tests show raised bile acids and mild liver test changes. ICP usually starts in the second or third trimester and gets better quickly after birth. It can increase risks for the baby, such as preterm birth, meconium in the amniotic fluid, and stillbirth, especially when bile acid levels are very high.
Gravidic intrahepatic cholestasis (also called intrahepatic cholestasis of pregnancy, ICP) is a liver problem that happens only in pregnancy. Bile (a digestive fluid made by the liver) does not flow out properly and builds up in the blood. This build-up causes very strong itching, usually on the palms of the hands and soles of the feet, often worse at night, and there is usually no rash.
ICP usually appears in the third trimester and almost always gets better after delivery. It is linked to higher levels of bile acids in the mother’s blood and a higher risk of problems for the baby, such as preterm birth, fetal distress, or, rarely, stillbirth, which is why close monitoring and planned delivery are very important.
Other Names
Gravidic intrahepatic cholestasis is known by several other names. These include “intrahepatic cholestasis of pregnancy (ICP),” “obstetric cholestasis,” “cholestasis of pregnancy,” “jaundice of pregnancy,” and older terms such as “prurigo gravidarum.” All of these terms describe the same basic problem: pregnancy-related blockage of bile flow inside the liver, with itching and high bile acids, that resolves after delivery. The different names appear in books, guidelines, and older research from many countries, but today “intrahepatic cholestasis of pregnancy” and “obstetric cholestasis” are the most common terms.
Types of Gravidic Intrahepatic Cholestasis
Doctors often group ICP by how high the bile acid level is in the blood. Mild ICP usually means total bile acids between about 10–39 µmol/L. Symptoms such as itching can still be very strong, but the baby’s risk is lower. Management usually focuses on symptom relief, blood test monitoring, and careful fetal follow-up.
Moderate ICP usually refers to bile acids between about 40–99 µmol/L. At this level, the risk of problems for the baby, including preterm birth or distress, clearly increases. Doctors often arrange closer monitoring, more frequent blood tests, and may suggest planned early birth around late preterm or early term, depending on guidelines and local practice.
Severe ICP usually means bile acids ≥100 µmol/L. This group has the highest risk of stillbirth and serious fetal complications. In these pregnancies, obstetric teams usually offer intensive fetal surveillance, consider medications to reduce bile acids, correct vitamin K deficiency, and often recommend planned delivery earlier than the due date to reduce risk for the baby.
Some experts also describe early-onset ICP (starting in the first or early second trimester) and late-onset ICP (starting in the third trimester). Early-onset disease is less common and raises stronger suspicion for underlying liver disease or stronger genetic factors. Late-onset disease is more typical and often closely linked to the very high hormone levels of late pregnancy.
Causes of Gravidic Intrahepatic Cholestasis
Genetic susceptibility in bile transport genes
Some women have changes in genes that control bile salt pumps in liver cells, such as ABCB4, ABCB11, or ATP8B1. These small changes do not cause constant disease on their own. However, when pregnancy hormones rise, the weakened pumps cannot move bile efficiently, so bile acids build up and cholestasis appears during pregnancy.High estrogen levels in late pregnancy
During the third trimester, estrogen levels are very high. Estrogen and its metabolites can directly slow bile flow and reduce the activity of bile transporters in genetically sensitive women. This hormone effect is a key reason ICP appears mainly in pregnancy and improves quickly once hormone levels fall after birth.High progesterone and sulfate metabolites
Progesterone and special sulfate forms of progesterone also rise in pregnancy. Some of these metabolites have cholestatic effects: they can interfere with bile acid export and change the composition of bile. In women whose liver transport system is borderline weak, these metabolites can push the system into cholestasis.Multiple pregnancy (twins or more)
Twin and higher-order pregnancies have even higher hormone levels, especially estrogen and progesterone. This stronger hormonal load puts extra strain on the liver’s bile transport system. Studies show that ICP is more common in twin pregnancies and often more severe when it occurs.Assisted reproduction and fertility treatments
Women who conceive using in-vitro fertilisation or other assisted methods may receive high-dose hormones. These treatments can increase estrogen and progesterone exposure early in pregnancy. In susceptible women, this extra hormonal stress may trigger ICP earlier or make it more severe.Previous history of ICP
If a woman has had ICP in one pregnancy, the chance of it returning in a later pregnancy is high. This strong recurrence pattern suggests a stable underlying susceptibility, such as genetic factors or a fixed liver trait, that is re-triggered whenever pregnancy hormones rise again.Family history in mother or sisters
ICP often runs in families. If a woman’s mother or sister had ICP, her risk is higher than average. This pattern again supports a genetic basis, where several family members share similar bile transport or hormone-response genes that become problematic in pregnancy.Chronic hepatitis C infection
Women with chronic hepatitis C have a higher chance of ICP. Hepatitis C can damage the liver cells and bile canaliculi. When pregnancy adds hormonal stress, the already vulnerable liver may not handle bile properly, leading to cholestasis. Screening for hepatitis C is often recommended in ICP.Other chronic liver diseases
Pre-existing liver conditions—such as non-alcoholic fatty liver disease, chronic hepatitis B, autoimmune hepatitis, or primary biliary cholangitis—can weaken bile handling. Pregnancy hormones can then push the liver into cholestasis. In women with ICP, doctors often test for these underlying liver diseases.Gallstones or biliary sludge
Gallstones and thick bile (sludge) in the gallbladder or bile ducts can slow bile flow or cause partial blockage. In pregnancy, when bile composition changes, these stones may make cholestasis more likely, especially in women with other risk factors. Ultrasound is used to look for these problems.Cholestatic medicines
Some medicines can cause cholestasis on their own, such as certain antibiotics, anabolic steroids, and estrogen-containing birth-control pills. Women with a history of drug-induced cholestasis are more likely to develop ICP when exposed to pregnancy hormones, because their bile system is already sensitive.Low selenium or micronutrient deficiencies
Research has suggested that low levels of selenium and other micronutrients may impair liver antioxidant defenses and bile transporter function. In areas with lower dietary selenium, ICP rates appear higher. This suggests that nutrition may modify the risk of cholestasis in pregnancy.Seasonal and environmental factors
ICP is more common in winter and in high-latitude countries such as Chile and Scandinavian nations. This seasonal pattern may reflect changes in diet, sunlight (vitamin D), or environmental toxins that influence bile formation or hormone metabolism during pregnancy.Maternal age over 35 years
Several studies have shown slightly higher rates of ICP in women aged 35 years or older. Older mothers may have more underlying liver vulnerability, more metabolic risk factors, or a longer history of medication or viral exposure, making cholestasis more likely when pregnancy hormones rise.Obesity and metabolic syndrome
Obesity and insulin resistance can lead to fatty liver and reduced bile flow, even before pregnancy. When pregnancy adds extra metabolic and hormonal stress, this background liver fat can worsen cholestasis risk. Many guidelines highlight weight and metabolic health as important modifiers.Ethnic and regional background
ICP rates are higher in some ethnic groups, such as women of South American, Scandinavian, or certain Asian backgrounds. This likely reflects different genetic variants in bile transport and hormone metabolism, combined with local diet and environment.Pregnancy complications that stress the liver
Conditions such as preeclampsia, HELLP syndrome, or acute fatty liver of pregnancy can overlap with or unmask ICP. In some cases, cholestasis develops in a liver already under stress from these pregnancy-specific disorders, making careful differential diagnosis important.Changes in the gut microbiome
Recent research suggests that changes in intestinal bacteria during pregnancy can alter bile acid composition and signaling. In susceptible women, these microbiome shifts may impair bile acid recycling and promote cholestasis, adding to the effects of genes and hormones.Previous gallbladder or liver surgery
Women who have had gallbladder removal or liver surgery may have altered bile pathways. When pregnancy increases bile acid production, these altered pathways might not cope well, predisposing to cholestasis. This is one of several structural factors considered during assessment.Idiopathic (no clear cause)
In many women with ICP, no single clear cause is found, even after careful testing. In these cases, doctors assume a mix of subtle genetic, hormonal, and environmental influences that only become visible when bile acid levels rise during pregnancy. The disease still behaves like typical ICP and resolves after birth.
Symptoms of Gravidic Intrahepatic Cholestasis
Intense itching of palms and soles
The classic symptom of ICP is strong itching on the palms of the hands and soles of the feet, often without any primary rash. The itch may feel burning or crawling and is usually worse at night. This pattern is highly suggestive of cholestasis in a pregnant woman.Generalized body itching
Although the palms and soles are most typical, the itch can spread to the arms, legs, trunk, and scalp. Some women feel itchy all over. Persistent, widespread itch without a rash in pregnancy should always prompt blood tests to look for ICP.Itching worse at night with poor sleep
Many women with ICP describe the itch as much worse in the evening and at night. This makes it hard to fall asleep or stay asleep. Poor sleep then leads to daytime tiredness, mood changes, and reduced quality of life during the pregnancy.No primary rash, only scratch marks
In ICP, the skin usually looks normal at first. There is no primary rash, blisters, or bumps caused by the disease itself. Over time, scratch marks, small scabs, and broken skin can appear because the woman has scratched so much to relieve the itch.Dark urine
Bile pigments that should go into the gut may spill into the urine. This can make urine appear darker than usual, like tea or cola. Dark urine in pregnancy together with itching and abnormal liver tests is a warning sign of cholestasis or other liver disease.Pale or light-colored stools
Because less bile reaches the intestine, stools may become pale, clay-colored, or greasy. Bile normally gives stools their brown color and helps digest fat. When bile is missing, stool color changes and fat absorption can be reduced.Jaundice (yellow eyes and skin)
A small proportion of women with ICP develop jaundice. The whites of the eyes and sometimes the skin become yellow because bilirubin builds up in the blood. Jaundice can also come from other serious liver diseases in pregnancy, so it always needs urgent medical evaluation.Fatigue and weakness
Constant itching, sleep loss, and mild liver dysfunction often lead to significant tiredness and weakness. Many women with ICP feel drained, find it hard to manage daily tasks, and may feel their pregnancy is much harder than expected.Poor sleep and irritability
Severe night-time itch disturbs sleep and can cause irritability, low mood, and difficulty concentrating. These emotional effects do not come from liver toxins directly but from the relentless itch and worry about the baby’s safety.Nausea and reduced appetite
Some women with ICP experience nausea, reduced appetite, or a general feeling of being unwell. These symptoms are non-specific but may be linked to bile acid buildup, altered digestion of fat, and the overall stress of poor sleep and itch.Right upper abdominal discomfort
Occasionally, women report discomfort or a dull ache under the right ribs, where the liver and gallbladder sit. This may reflect liver enlargement, gallbladder issues, or referred pain from the liver capsule, and calls for careful evaluation to exclude other liver diseases.Greasy stools and bloating
If bile flow into the intestine is reduced, fat digestion can be impaired, leading to greasy stools, bloating, and gas. Over time, this may contribute to deficiencies of fat-soluble vitamins such as vitamins A, D, E, and K, which are important for both mother and baby.Easy bruising or bleeding
Vitamin K is a fat-soluble vitamin that depends on bile for absorption. In ICP, poor bile flow may lower vitamin K levels, leading to longer clotting times. Women may notice easy bruising or more bleeding from small cuts, and there is concern about bleeding at delivery without supplementation.Anxiety about baby’s movements
Because ICP is linked with fetal risks, mothers often become very aware of fetal movements. Any perceived reduction or change in movement pattern can cause anxiety and stress, leading to more frequent checks and hospital visits for reassurance and monitoring.Perceived reduced fetal movements or distress
Sometimes women notice real changes, such as fewer or weaker fetal kicks. This may reflect fetal distress or growth problems, especially when bile acids are very high. In such cases, urgent assessment with fetal monitoring and ultrasound is recommended.
Diagnostic Tests for Gravidic Intrahepatic Cholestasis
Physical examination tests
General physical examination
The clinician examines the whole body, looking for scratch marks, jaundice, signs of anemia, swelling, and blood pressure problems. They also assess general well-being. This basic exam helps distinguish ICP from other liver and pregnancy conditions that can also cause itching and abnormal tests.Obstetric abdominal examination
The abdomen is gently felt to check the size of the uterus, the baby’s position, and amniotic fluid volume. This helps identify growth restriction or polyhydramnios, which may be linked to ICP or other complications and may change surveillance and delivery plans.Clinical assessment of stool and urine changes
Through questions and, when needed, observation, the doctor checks for dark urine and pale stools. These simple clinical clues strongly point toward cholestasis or other liver disease and guide the decision to order bile acid and liver tests.
Manual tests (bedside clinical tools)
Pruritus severity scale or visual analogue scale (VAS)
The woman is asked to rate her itch on a line or scale, for example from 0 (no itch) to 10 (worst possible itch). This simple manual tool helps track symptom severity over time and evaluate the effect of treatments like topical agents or bile acid-lowering drugs.Symptom diary and sleep log
Patients may be asked to keep a written diary of itching episodes, sleep quality, and triggers. This manual record gives a clearer picture of daily impact, helps distinguish ICP from short-lived skin problems, and supports shared decisions about timing of delivery.Bedside obstetric palpation and fetal kick counting teaching
During routine visits, the clinician manually palpates the uterus to feel the baby’s movements and position, and teaches the mother how to count fetal kicks at home. This hands-on assessment helps detect changes in fetal activity that may signal distress in women with ICP.
Lab and pathological tests
Serum total bile acid level
This is the key blood test for ICP. A sample of blood is checked for the total concentration of bile acids. Levels above a certain threshold confirm cholestasis in the right clinical context, and higher levels are linked with higher risks for the baby and influence delivery timing.Fractionated bile acid profile
Some laboratories measure individual bile acids, such as cholic and chenodeoxycholic acid. The pattern can help research and sometimes risk assessment, as certain bile acids may be more toxic to the placenta and fetus than others, especially at very high levels.Liver function tests (ALT and AST)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are enzymes released when liver cells are stressed. In ICP they may be mildly to moderately raised. However, they can also be normal, so they support but do not replace bile acid testing.Serum bilirubin (total and direct)
Bilirubin levels measure how well the liver processes and excretes this pigment. In many ICP cases, bilirubin is normal or slightly raised. Higher levels, especially with jaundice, require careful evaluation to rule out other liver diseases or overlapping pregnancy liver disorders.Gamma-glutamyl transferase (GGT)
GGT is a liver enzyme linked with bile ducts. In ICP, it may be normal or mildly elevated. Patterns of GGT together with other tests help distinguish ICP from obstructive bile duct disease or other cholestatic liver problems.Alkaline phosphatase (ALP)
ALP is naturally higher in pregnancy due to placental production, so it is less specific. However, very high ALP levels can still support a cholestatic pattern when seen with raised bile acids and other abnormal liver tests. Interpretation always considers the pregnancy state.Coagulation profile (PT/INR) and vitamin K status
Prothrombin time (PT) and the INR show how well the blood clots. In ICP, fat malabsorption can lower vitamin K and prolong PT/INR. Testing allows timely vitamin K supplementation to protect the mother and baby from bleeding at birth.Complete blood count (CBC)
A CBC checks hemoglobin, white cells, and platelets. It helps detect anemia, infection, or low platelets that might point to other pregnancy conditions like HELLP syndrome. In ICP, the CBC is often normal but is still important for overall assessment and delivery planning.Viral hepatitis panel
Blood tests for hepatitis A, B, C, and E viruses help rule out viral hepatitis, which can also cause itch, jaundice, and raised liver tests. Distinguishing viral infection from ICP is vital, because management, prognosis, and infection-control steps are very different.Autoimmune liver disease screen
Tests for autoantibodies (such as ANA, SMA, AMA) and immunoglobulin levels look for autoimmune liver diseases like autoimmune hepatitis or primary biliary cholangitis. These conditions can mimic or coexist with ICP and may require long-term treatment beyond pregnancy.
Electrodiagnostic test
Electronic fetal monitoring (cardiotocography, non-stress test)
In cardiotocography, sensors are placed on the mother’s abdomen to record the baby’s heart rate and uterine contractions over time. In ICP, this electronic monitoring is often used to watch for signs of fetal distress, especially when bile acids are high or delivery is being planned.
Imaging tests
Obstetric ultrasound for fetal growth and amniotic fluid
Ultrasound uses sound waves to create images of the baby and uterus. In ICP, regular obstetric scans help check fetal growth, fluid volume, and placenta. Abnormal findings may influence how often monitoring is done and when delivery should be offered.Liver and gallbladder ultrasound
An ultrasound of the upper abdomen looks at liver texture, bile ducts, and the gallbladder. It helps rule out gallstones, bile duct blockage, or other structural problems that can also cause cholestasis and jaundice, ensuring the diagnosis truly fits ICP.Doppler ultrasound of fetal and placental vessels
Doppler ultrasound measures blood flow in the umbilical cord and fetal vessels. In high-risk ICP cases, this test helps assess placental function and fetal well-being. Abnormal Doppler findings may support decisions for closer surveillance or earlier birth to protect the baby.
Non-pharmacological treatments (therapies and others)
1. Close obstetric and liver specialist follow-up
Regular visits with an obstetrician and, if possible, a hepatologist help track bile acids, liver enzymes, and the baby’s wellbeing. This allows early action if bile acids rise or the baby shows distress, which lowers the risk of complications.
2. Frequent bile acid and liver blood tests
Blood tests for total serum bile acids and liver enzymes (ALT, AST, ALP, bilirubin) help confirm ICP and guide decisions about medicines and timing of delivery. Higher bile acids are linked with higher fetal risk, so these tests are repeated regularly.
3. Fetal monitoring with cardiotocography (CTG / NST)
Non-stress tests (NSTs) and cardiotocography check baby’s heart rate pattern and movements. Although they cannot completely prevent sudden events, they may help detect early signs of fetal distress so doctors can act quickly.
4. Ultrasound and biophysical profile
Ultrasound is used to follow fetal growth, amniotic fluid volume, and sometimes a biophysical profile (movement, breathing, tone, fluid). This helps detect growth restriction or other problems that are more common in pregnancies affected by ICP.
5. Planned early delivery
One of the most important “non-drug” interventions is planned delivery, often between 36–39 weeks, with earlier delivery in women with very high bile acids or other risks. Delivering before bile acids become extremely high may reduce the risk of stillbirth.
6. Cool baths or showers for itch relief
Cool or lukewarm baths, showers, or cool compresses can briefly calm the skin and lessen itching. They do not change bile acids but may help the mother feel more comfortable and sleep a little better at night.
7. Loose, breathable clothing
Soft, loose cotton clothing and avoiding wool or rough fabrics reduce skin irritation. Breathable clothes help the skin stay cool, which may slightly reduce the intensity of itching, especially in hot and humid climates.
8. Unscented moisturisers and emollients
Simple fragrance-free moisturisers or emollients can soothe dry, irritated skin and help protect the skin barrier from damage caused by constant scratching. They do not treat the liver problem but can reduce discomfort and scratching injuries.
9. Sleep hygiene and rest planning
Because itching is often worst at night, planning short daytime rests, using relaxation techniques, and creating a cool, dark bedroom may help reduce sleep loss and fatigue. Better rest can also improve mood and coping with symptoms.
10. Psychological and emotional support
ICP can be frightening because of worries about the baby. Talking with a midwife, counselor, or support group can help reduce anxiety, depression, and stress, which themselves may worsen the feeling of itch and disturb sleep.
11. Education about warning signs
Clear education about symptoms such as new jaundice, dark urine, pale stools, reduced fetal movements, or vaginal bleeding helps the pregnant person know when to seek urgent care. Quick response to warning signs can protect both mother and baby.
12. Avoiding alcohol and unnecessary liver-toxic drugs
Completely avoiding alcohol and avoiding unnecessary medicines that may harm the liver (for example, high-dose paracetamol or certain herbal remedies) reduces extra stress on the liver that is already struggling with cholestasis. All medicines should be checked with a doctor.
13. Reviewing hormonal medicines
Some women with a history of ICP may get worse itching with estrogen-containing contraceptive pills or fertility medicines. Doctors may choose lower-risk options or different doses to reduce the chance of triggering cholestasis again.
14. Phototherapy (narrowband UVB) for refractory itch
In very difficult, long-lasting cholestatic pruritus (usually not in pregnancy), narrowband UVB phototherapy has shown benefit in small studies. In pregnancy it would only be considered by specialists if safer methods fail and risks and benefits are carefully weighed.
15. Stepwise pruritus management plans
Specialist protocols for cholestatic itch usually follow a ladder: bile acid sequestrant first, then rifampin, then opioid antagonists, SSRIs, or other agents, adjusting for pregnancy safety. Having a plan helps avoid random drug changes and improves safety.
16. Active management of labour and third stage
For women with ICP, guidelines often recommend active management of labour and the third stage (delivery of the placenta) to limit bleeding risk, and careful monitoring for postpartum haemorrhage, especially if there is vitamin K deficiency.
17. Postpartum follow-up of liver tests
After birth, itching usually improves quickly, and bile acids and liver enzymes should return to normal within weeks. A follow-up test around 6–12 weeks confirms recovery and helps detect rare underlying liver disease.
18. Planning future pregnancies
Women who had ICP have a high chance of getting it again in future pregnancies. Pre-pregnancy counselling lets them plan early monitoring, discuss contraception options, and review liver health before conceiving again.
19. Lifestyle support: nutrition, gentle activity, weight
Eating a balanced pregnancy-appropriate diet, staying active as advised, and avoiding excessive weight gain can support overall liver and metabolic health, though they cannot fully prevent ICP, which is often genetic and hormonal.
20. Partner and family involvement
Involving the partner or family in appointments and education helps them understand why monitoring, medications, and sometimes early delivery are needed. This support can make it easier for the pregnant person to follow medical advice and manage stress.
Drug treatments
(All doses are examples from clinical and regulatory sources; actual dose and choice must be set by the treating doctor, especially in pregnancy.)
1. Ursodeoxycholic acid (UDCA, ursodiol)
UDCA is the main medicine used in ICP. It is a bile acid that replaces more toxic bile acids, improves bile flow, lowers bile acids in the blood, and often reduces itching. Common doses are about 10–15 mg/kg/day in divided doses.
2. Ursodiol (URSO formulations)
URSO 250 and URSO Forte are FDA-approved ursodiol products for certain cholestatic liver diseases; they are often used off-label in ICP. Label information describes bile-acid replacement, mainly fecal excretion, and chronic doses of 13–15 mg/kg/day in adults.
3. Cholestyramine resin
Cholestyramine is a bile acid sequestrant powder that binds bile acids in the gut and helps reduce pruritus in cholestatic disease. It can worsen fat-soluble vitamin (especially vitamin K) deficiency, so vitamin monitoring and supplementation may be needed.
4. Colestipol
Colestipol is another bile acid sequestrant that works similarly to cholestyramine by binding bile acids and reducing re-absorption. It may be used when cholestyramine is not tolerated, but the same concerns about vitamin K and drug interactions apply.
5. Rifampin (rifampicin)
Rifampin is an antibiotic that also activates pregnane X receptor (PXR) and changes bile acid metabolism, which can markedly reduce severe cholestatic pruritus when first-line drugs fail. It requires close monitoring of liver function and drug interactions, especially in pregnancy.
6. S-adenosyl-L-methionine (SAMe)
SAMe is a methyl-group donor involved in liver metabolism. Intravenous SAMe has been used for cholestatic liver disease and ICP but is less convenient because it often needs twice-daily IV infusions; UDCA appears more effective for lab tests, with similar itch relief.
7. Chlorpheniramine
Chlorpheniramine is a sedating antihistamine used mainly to relieve itching and help sleep. It does not reduce bile acids but may reduce the feeling of itch and is often chosen because of its longer history of use in pregnancy.
8. Hydroxyzine
Hydroxyzine is another antihistamine with sedating and anxiolytic effects that may ease itching and improve sleep. In pregnancy, doctors weigh its benefits against potential fetal risks and usually use the lowest effective dose for the shortest time.
9. Dexamethasone
Dexamethasone, a corticosteroid, has been studied for ICP but shows limited or inconsistent benefit for pruritus and bile acids. Because steroids have significant maternal and fetal side effects, they are not first choice and are used only in special circumstances.
10. Vitamin K (phytonadione)
Vitamin K injections or oral doses may be given to mothers with prolonged clotting times or who are taking cholestyramine or rifampin, and to newborns at birth. This reduces bleeding risk by correcting vitamin K deficiency caused by fat-malabsorption.
11. Naltrexone
Naltrexone is an oral opioid-receptor antagonist that can reduce severe cholestatic pruritus by blocking opioid pathways involved in itch perception. Trials in chronic cholestasis show benefit, but use in pregnancy is limited and must be specialist-led.
12. Sertraline (SSRI)
Sertraline, an antidepressant, has shown antipruritic effects in chronic cholestatic itch, possibly by changing serotonin pathways involved in itch perception. It may be considered only for very refractory cases, balancing benefits for mental health and itch against rare liver toxicity risks.
13. Bezafibrate
Bezafibrate is a fibrate that can improve cholestatic pruritus in conditions like primary biliary cholangitis. It acts on PPAR receptors, improving bile acid handling. Data in pregnancy ICP are sparse, so it would be reserved for specialist situations.
14. Gabapentin
Gabapentin is an anticonvulsant used off-label for chronic pruritus in some liver diseases. Trials show mixed results, and it is not a standard ICP drug, but it may be considered for severe itch outside pregnancy or in very carefully selected cases.
15. Topical menthol or calamine lotions
Though not systemic “drugs”, menthol or calamine lotions can cool the skin and provide temporary itch relief. They are generally considered low-risk in pregnancy, but they do not treat the underlying cholestasis or change bile acid levels.
16. Colesevelam
Colesevelam is a newer bile acid sequestrant sometimes used as an alternative to cholestyramine. It binds bile acids in the intestine and may reduce pruritus, but data in pregnancy and ICP are limited, so use is specialist-directed.
17. Ursodeoxycholic acid plus SAMe combination
Some studies combined UDCA and SAMe to try to improve outcomes further. Combination therapy may improve liver tests and itch in some women, but it is more complex and costly and not clearly superior to UDCA alone.
18. Combination of bile acid sequestrant plus rifampin
In severe chronic cholestatic pruritus, guidelines sometimes combine cholestyramine with rifampin in a stepwise approach. This may also be considered in very severe ICP under specialist care, with very careful monitoring for liver toxicity and vitamin deficiencies.
19. Ondansetron (limited role)
Ondansetron is an anti-nausea drug sometimes studied for itch, but evidence for benefit in cholestatic pruritus is weak or inconsistent, and it is not a main treatment for ICP. It may still be used mainly to treat pregnancy-related nausea.
20. Experimental ileal bile acid transporter (IBAT) inhibitors
New drugs such as odevixibat and similar IBAT inhibitors reduce bile acid re-absorption and help cholestatic pruritus in some pediatric liver diseases. They are not standard in ICP and any use in pregnancy would be strictly experimental.
Dietary molecular supplements
(Always check safety and dose with your obstetrician; many “natural” products can still harm the liver or the baby.)
1. Prenatal folate and B-complex vitamins
Folate and B-vitamins support cell growth, red blood cell production, and liver enzyme reactions. Standard prenatal doses are usually safe and recommended in pregnancy, but they do not directly cure ICP; they simply support general maternal health.
2. Vitamin D (within pregnancy-safe range)
Many pregnant women have low vitamin D. Correcting deficiency supports bone, immune, and possibly liver health. Doses must follow pregnancy guidelines because very high doses can be toxic and are not proven to treat ICP.
3. Omega-3 fatty acids (fish oil from low-mercury sources)
Omega-3 fats may help reduce inflammation and improve lipid metabolism. In pregnancy, low-mercury fish or purified supplements can be used in safe doses. They are not a main ICP therapy but may support cardiovascular and metabolic health.
4. Choline
Choline is important for liver fat transport and cell membranes. Adequate choline intake in pregnancy helps normal liver and brain development of the fetus, though it is not specific therapy for ICP and should not be taken in mega-doses.
5. Antioxidant vitamins C and E (food-based)
Antioxidants may protect liver cells from oxidative stress. Getting them from fruits, vegetables, and nuts is preferred over high-dose pills, because large supplement doses have not shown clear benefit in ICP and sometimes increase other risks.
6. Selenium and zinc (correcting deficiency only)
Selenium and zinc are trace minerals used by antioxidant and immune enzymes. Correcting proven deficiency may support liver and immune function, but routine high-dose use is not recommended in pregnancy without blood-test guidance.
7. Probiotics
Probiotic foods or supplements may modestly influence bile acid metabolism through gut bacteria. Evidence is still early, but they may help overall gut health and constipation in pregnancy when taken in typical food-level doses.
8. Mild fibre supplements (psyllium, oats)
Adequate fibre supports regular bowel movements and may help bind some bile acids naturally, but this effect is small compared with medicines. Too much fibre or abrupt changes can cause bloating, so changes should be gradual.
9. Whey or plant-based protein supplements (if needed)
For women struggling to eat due to nausea and itch, a pregnancy-safe protein supplement can help maintain nutrition. However, high-protein supplements with added herbs or stimulants should be avoided because of unknown liver effects.
10. Avoiding unregulated “liver detox” supplements
Many commercial “detox” or herbal liver products can worsen liver injury or interact with pregnancy medicines. The safest “supplement” is usually a balanced diet plus standard prenatal vitamins unless a doctor prescribes something specific.
Immunity-booster, regenerative and “stem cell” drugs
1. No approved stem-cell drug for ICP
There are currently no stem-cell or regenerative drugs approved specifically for ICP. Stem-cell therapies are still mainly research treatments for severe chronic liver diseases and are not recommended in pregnancy outside carefully controlled clinical trials.
2. Hepatoprotective strategies focus on bile acids, not immune boosters
Modern management of ICP focuses on lowering toxic bile acids and planning safe delivery, rather than trying to “boost immunity.” Drugs like UDCA and rifampin aim to change bile acid handling, not general immunity.
3. Experimental cell-based therapies in chronic cholestasis
Mesenchymal stem cells and other cell-based therapies are being studied for advanced liver fibrosis and cirrhosis, sometimes related to chronic cholestatic disease. These trials exclude pregnant women, so such approaches are not part of ICP care.
4. Growth-factor and bile-acid pathway drugs
New drugs that target autotaxin–lysophosphatidic acid pathways, IBAT transporters, or nuclear receptors such as FXR and PXR are under study for cholestatic pruritus. They remain experimental and are not routine in pregnancy.
5. General immune support via vaccination and infection control
Keeping vaccines up to date (as recommended in pregnancy), hand hygiene, and avoiding infections protect both mother and baby. This is “immune support” in a safe, evidence-based way rather than using unproven immune-boosting pills.
6. Focus on safe nutrition, sleep, and mental health as regenerative factors
Good nutrition, sleep, and mental health support the body’s natural repair systems. These simple, low-risk methods are the safest “regenerative” strategies during pregnancy and complement, but never replace, medical treatment for ICP.
Surgeries and procedures
1. Induction of labour (planned vaginal delivery)
Induction of labour at 36–39 weeks, earlier if bile acids are very high or other risks are present, is the key “procedure” in ICP. It aims to balance lung maturity of the baby with the rising risk of stillbirth from high bile acids.
2. Caesarean section when indicated
Caesarean birth is not required just because of ICP, but it is performed if usual obstetric indications are present (breech, fetal distress, failed induction). In severe ICP, a lower threshold for caesarean may be used if fetal monitoring is concerning.
3. Management of gallstones or bile duct obstruction
Some women with ICP also have gallstones or other bile-duct problems. In rare cases, ERCP (endoscopic removal of stones) or surgery during or after pregnancy may be needed to relieve obstruction and reduce cholestasis.
4. Postpartum cholecystectomy for recurrent gallstones
If gallstones cause repeated pain or pancreatitis, removal of the gallbladder after pregnancy may be advised. This does not directly treat ICP but can prevent future biliary problems that could confuse or worsen liver tests.
5. Liver transplant in rare underlying disease
Very rarely, ICP unmasks a severe underlying liver disease. In such cases, if liver failure develops later, transplantation can be life-saving. This is usually long after the pregnancy and is not a routine ICP treatment.
Preventions
1. Early antenatal booking and disclosure of past ICP
Women with a past history of ICP should tell their care team early in pregnancy, so monitoring of bile acids and liver function can start promptly, before severe symptoms appear.
2. Regular bile-acid checks in high-risk women
Women with previous ICP, multiple pregnancy, hepatitis, or strong family history may benefit from earlier and more frequent bile-acid checks, even before itch becomes severe.
3. Careful choice of contraception after pregnancy
Because estrogen can trigger cholestasis, women with prior ICP may be advised to avoid high-estrogen contraceptive pills and use lower-risk methods like progestin-only or non-hormonal methods instead.
4. Avoid alcohol and recreational drugs
Alcohol and many recreational drugs can damage the liver. Completely avoiding them before and during pregnancy reduces additional liver stress and may lower the chance of overlapping liver injuries.
5. Vaccination against hepatitis where appropriate
Vaccines for hepatitis A and B (when advised) protect against viral liver infections. Preventing extra liver injury is especially important in women who already have a higher risk of cholestasis.
6. Healthy weight before and during pregnancy
Obesity and metabolic syndrome can worsen liver health, including non-alcoholic fatty liver disease. Reaching a healthy weight before pregnancy and avoiding excessive weight gain may reduce combined liver stresses.
7. Avoid herbal remedies without medical review
Many herbs marketed for “liver cleansing,” weight loss, or stress are not tested in pregnancy and may cause drug-induced liver injury or drug interactions, making cholestasis worse. Always ask a doctor before using them.
8. Prompt review of any unexplained itching in pregnancy
Because itching of ICP often starts before lab tests change a lot, any new, unexplained itch—especially on hands and feet at night—should be checked quickly by a midwife or doctor with bile-acid testing.
9. Regular review of existing liver disease before pregnancy
Women with chronic liver conditions (hepatitis, PBC, PSC, etc.) should have pre-pregnancy counselling to optimise treatment, adjust medicines, and discuss pregnancy risks including cholestasis.
10. Education on fetal movement awareness
Teaching mothers to notice their baby’s usual movement pattern and to seek help if movements slow down helps early detection of fetal distress, which is important in ICP where sudden events can rarely occur.
When to see doctors
You should contact a midwife or doctor as soon as possible if you are pregnant and have intense itching, especially on the palms and soles, that is worse at night and not explained by a rash or allergy.
Seek emergency care if you notice yellowing of the skin or eyes (jaundice), very dark urine, very pale stools, severe right-upper-abdominal pain, reduced or absent fetal movements, vaginal bleeding, or signs of preterm labour, because these can signal serious complications.
What to eat and what to avoid
1. Eat: balanced meals with complex carbohydrates
Choose whole grains, vegetables, fruits, and legumes to keep energy steady and support liver metabolism. Avoid large amounts of refined sugar that may worsen weight gain and metabolic stress.
2. Eat: lean proteins
Include fish (low-mercury), poultry, beans, and lentils for protein to support fetal growth and liver repair. Avoid heavily processed meats high in salt and saturated fat.
3. Eat: healthy fats in small amounts
Use small amounts of olive oil, nuts, seeds, and avocado. Very high-fat meals can increase bile flow demands, so spreading fat through the day in small portions is usually more comfortable.
4. Avoid: alcohol completely
Alcohol is a strong liver toxin and should be completely avoided in pregnancy and especially in ICP, because it adds to liver stress and increases risk of complications.
5. Avoid: very greasy, fried foods
Large, oily meals can worsen nausea, reflux, and discomfort and may increase bile load. Choosing grilled, baked, or steamed foods is easier for both liver and digestion.
6. Eat: plenty of fruits and vegetables
Colourful fruits and vegetables provide fibre, vitamins, and antioxidants that support general health and help prevent constipation, which can make itching and discomfort feel worse.
7. Avoid: herbal teas and supplements without checking
Some herbal teas and “natural” remedies can harm the liver or affect hormones. In ICP, it is safer to avoid them unless your doctor confirms they are safe in pregnancy.
8. Eat: small, frequent meals
Smaller meals eaten more often can be easier to tolerate if you have nausea or discomfort and may prevent long periods of fasting, which is stressful in late pregnancy.
9. Stay hydrated with water
Adequate fluid intake supports circulation, kidney function, and overall wellbeing. Sugary drinks should be limited to avoid extra calories and blood-sugar spikes.
10. Follow any special diet from your care team
If you also have diabetes, pre-eclampsia, or other conditions, your doctors may give a specific eating plan. Following this is more important than general advice because it is tailored to your full health picture.
FAQs
1. Is gravidic intrahepatic cholestasis dangerous for the baby?
Yes, ICP can increase risks such as preterm birth, meconium in the amniotic fluid, fetal distress, and, rarely, stillbirth. Careful monitoring, medicines like UDCA, and planned delivery greatly reduce these risks.
2. Does the itching harm my baby directly?
The itching itself does not harm the baby, but the high bile acids that cause the itch are linked with higher fetal risk, which is why treatment and monitoring are so important.
3. Will ICP go away after birth?
In most women, itching improves within a few days after delivery and bile acids and liver tests return to normal within weeks. Follow-up blood tests confirm that everything has settled.
4. Will I get ICP again in another pregnancy?
Yes, recurrence is common; many studies show a high chance of ICP returning in future pregnancies. That is why early monitoring is recommended if you had ICP before.
5. Can I breastfeed if I had ICP?
Most women with ICP can breastfeed normally. UDCA and many other treatments are often stopped after birth once bile acids fall, and breastfeeding is usually considered safe; always confirm with your doctor for your specific medicines.
6. Does ICP mean I will have lifelong liver disease?
For most women, ICP is temporary and does not cause permanent liver damage. However, some may have underlying liver or bile duct problems, so postpartum follow-up helps decide if any extra tests are needed.
7. Can I prevent ICP completely?
Because ICP is strongly related to hormones, pregnancy, and sometimes genes, it cannot be fully prevented. However, good liver health, early pregnancy care, and fast treatment when symptoms appear can reduce risks.
8. Is UDCA safe for my baby?
Current evidence shows UDCA improves maternal symptoms and may reduce bile acids, and it has not shown major harms for babies in available studies, though data are still being studied. Doctors use it widely but still monitor closely.
9. Can I use over-the-counter anti-itch creams instead of seeing a doctor?
OTC creams may give short-term relief but cannot treat the liver problem or protect the baby. Any new strong itch in pregnancy, especially on hands and feet, should be checked urgently by a professional.
10. Does ICP affect my baby’s development in the womb?
Most babies grow normally, but there is a higher risk of preterm birth and meconium staining. Growth scans and monitoring help ensure your baby is developing as expected.
11. Are there long-term effects on the child after birth?
Available data do not show major long-term problems for most children born after ICP, especially when pregnancies are monitored and delivered safely. Research is ongoing to watch long-term outcomes.
12. Can stress make ICP worse?
Stress does not cause ICP but can make itching feel more intense and disturb sleep. Psychological support, relaxation methods, and good sleep habits may help you cope better with symptoms.
13. Is ICP the same as a normal pregnancy rash?
No. ICP usually causes intense itch without a rash, especially on hands and feet, and is linked with abnormal bile-acid tests. Common pregnancy rashes usually have visible skin spots or bumps.
14. Should my baby receive vitamin K at birth?
Yes. All newborns should receive vitamin K to prevent bleeding, and it is especially important if the mother had ICP or used cholestyramine or rifampin, which can lower vitamin K levels.
15. Does ICP mean I cannot have more children?
Having ICP does not mean you must avoid future pregnancies, but you and your doctor should plan close monitoring, early testing, and clear delivery plans to keep future pregnancies as safe as possible.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: January 12, 2026.
